Search Ontology:
ChEBI
alvocidib
- Term ID
- CHEBI:47344
- Synonyms
-
- (-)-cis-5,7-dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one
- 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-4H-chromen-4-one
- alvocidib
- alvocidibum
- Flavopiridol
- HMR 1274
- HMR-1274
- L 86-8275
- L 868275
- L-868275
- L86-8275
- Definition
- A synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is substituted by a 3-hydroxy-1-methylpiperidin-4-yl group at position 8 and by a chlorine at the 2' position (the (−)-3S,4R stereoisomer). A cyclin-dependent kinase 9 (CDK9) inhibitor, it has been studied for the treatment of acute myeloid leukaemia, arthritis and atherosclerotic plaque formation.
- References
-
- cas:146426-40-6
- drugbank:DB03496
- kegg.drug:D09868
- lincs.smallmolecule:LSM-1011
- patent:EP241003
- patent:US4900727
- pdb-ccd:CPB
- pubmed:10441105
- pubmed:1279187
- pubmed:18209094
- pubmed:21541623
- pubmed:23959599
- pubmed:25118834
- pubmed:25216351
- pubmed:25351763
- pubmed:25623777
- pubmed:25860066
- pubmed:25989942
- pubmed:26022709
- pubmed:26521988
- pubmed:26599132
- pubmed:8002990
- pubmed:9269999
- pubmed:9815683
- wikipedia.en:Alvocidib
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alvocidib
Phenotype where environments contain alvocidib
Phenotype modified by environments containing alvocidib
Phenotype affecting alvocidib
Human Disease Model